Evaluation of ultrasound as diagnostic tool in patients with clinical features suggestive of carpal tunnel syndrome in comparison to nerve conduction studies: Study protocol for a diagnostic testing study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 24 01 2023
accepted: 10 09 2023
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: epublish

Résumé

Carpal Tunnel Syndrome (CTS) is the most common compressive neuropathy, accounting for 90% of all neuropathies. Its prevalence ranges from 3.8%-7.8% in the population. The gold standard for its diagnosis is the neurophysiological study (85% sensitivity and 95% specificity), with the disadvantage of being invasive, complex and expensive, which means an increase in cost and time for the diagnosis of the disease. The main objective of this diagnostic test evaluation study is to investigate the value of ultrasound in the diagnosis of CTS, and among the secondary objectives, to establish the ultrasound parameters that are predictors of CTS in comparison with neurophysiological studies, attempting to standardize a protocol and reference values that determine the presence or absence of CTS. Prospective, cross-sectional study. The reference test with which we compared the ultrasound is the neurophysiological test (NPT). Patients will come consecutively from the Neurophysiology Department of the Virgen Macarena Hospital, with clinical suspicion of CTS and fulfilling the inclusion/exclusion criteria. To calculate the sample size (EPIDAT program) we proposed a sensitivity of 78% and specificity of 87% with a confidence level of 95%, requiring 438 patients (264 NPT positive, 174 NPT negative). We followed an ultrasound study protocol that included the ultrasound variables: cross-sectional area at the entrance and exit of the tunnel, range of nerve thinning, wrist-forearm index, flexor retinaculum bulging, power Doppler uptake and the existence of adjacent wrists or masses. We propose a timeline for the study to be performed between 2020 and 2023. Finally, we propose a cost-effectiveness analysis. Ultrasound not only allows to objectify the alterations of the median nerve but also the underlying pathological mechanisms in CTS. A multitude of ultrasound parameters have been described that should be regarded in syndrome's study, among which we included the cross-sectional area, the range of nerve thinning, the wrist-forearm index, flexor retinaculum bulging, power Doppler uptake and assessment of anatomical alterations. The use of ultrasound as a diagnostic tool in CTS has many advantages for both doctors and the patients, as it is a non-invasive, convenient, and fast tool increasingly accessible to professionals. Trials registry number: NCT05556278.

Sections du résumé

BACKGROUND
Carpal Tunnel Syndrome (CTS) is the most common compressive neuropathy, accounting for 90% of all neuropathies. Its prevalence ranges from 3.8%-7.8% in the population. The gold standard for its diagnosis is the neurophysiological study (85% sensitivity and 95% specificity), with the disadvantage of being invasive, complex and expensive, which means an increase in cost and time for the diagnosis of the disease. The main objective of this diagnostic test evaluation study is to investigate the value of ultrasound in the diagnosis of CTS, and among the secondary objectives, to establish the ultrasound parameters that are predictors of CTS in comparison with neurophysiological studies, attempting to standardize a protocol and reference values that determine the presence or absence of CTS.
METHODS
Prospective, cross-sectional study. The reference test with which we compared the ultrasound is the neurophysiological test (NPT). Patients will come consecutively from the Neurophysiology Department of the Virgen Macarena Hospital, with clinical suspicion of CTS and fulfilling the inclusion/exclusion criteria. To calculate the sample size (EPIDAT program) we proposed a sensitivity of 78% and specificity of 87% with a confidence level of 95%, requiring 438 patients (264 NPT positive, 174 NPT negative). We followed an ultrasound study protocol that included the ultrasound variables: cross-sectional area at the entrance and exit of the tunnel, range of nerve thinning, wrist-forearm index, flexor retinaculum bulging, power Doppler uptake and the existence of adjacent wrists or masses. We propose a timeline for the study to be performed between 2020 and 2023. Finally, we propose a cost-effectiveness analysis.
DISCUSSION
Ultrasound not only allows to objectify the alterations of the median nerve but also the underlying pathological mechanisms in CTS. A multitude of ultrasound parameters have been described that should be regarded in syndrome's study, among which we included the cross-sectional area, the range of nerve thinning, the wrist-forearm index, flexor retinaculum bulging, power Doppler uptake and assessment of anatomical alterations. The use of ultrasound as a diagnostic tool in CTS has many advantages for both doctors and the patients, as it is a non-invasive, convenient, and fast tool increasingly accessible to professionals.
TRIAL REGISTRATION
Trials registry number: NCT05556278.

Identifiants

pubmed: 37948425
doi: 10.1371/journal.pone.0281221
pii: PONE-D-23-01320
pmc: PMC10637656
doi:

Banques de données

ClinicalTrials.gov
['NCT05556278']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0281221

Informations de copyright

Copyright: © 2023 Murciano Casas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

J Hand Surg Am. 2011 Jan;36(1):52-60
pubmed: 21131139
J Orthop Res. 2012 Nov;30(11):1732-7
pubmed: 22573580
Ann Rehabil Med. 2016 Dec;40(6):1040-1047
pubmed: 28119834
Eur J Transl Myol. 2018 Apr 24;28(2):7380
pubmed: 29991986
Muscle Nerve. 2002 Jun;25(6):918-22
pubmed: 12115985
Hand Clin. 2002 May;18(2):269-77, vi
pubmed: 12371029
J Ultrasound Med. 2016 Nov;35(11):2311-2324
pubmed: 27629754
Rev Neurol. 2014 Nov 16;59(10):459-69
pubmed: 25354508
Rheumatology (Oxford). 2006 May;45(5):584-8
pubmed: 16332951
Ultrasound Med Biol. 2013 Dec;39(12):2492-7
pubmed: 24139197
J Rheumatol. 2001 Jan;28(1):62-9
pubmed: 11196545
Neurol Neurochir Pol. 2011 Nov-Dec;45(6):556-560
pubmed: 22212985
Clin Neurophysiol. 2008 Jun;119(6):1353-7
pubmed: 18387336
Muscle Nerve. 2012 Dec;46(6):871-8
pubmed: 23041984
J Hand Surg Br. 1994 Dec;19(6):720-4
pubmed: 7706873
Clin Orthop Relat Res. 2011 Apr;469(4):1089-94
pubmed: 20963527
J Hand Surg Am. 1981 Jan;6(1):3-12
pubmed: 7204915
Muscle Nerve. 2003 Jan;27(1):26-33
pubmed: 12508291
Neural Plast. 2013;2013:754564
pubmed: 23864961
Hand Clin. 2002 May;18(2):219-30
pubmed: 12371025
J Hand Surg Eur Vol. 2008 Aug;33(4):435-9
pubmed: 18687830
Clin Radiol. 2004 Oct;59(10):916-25
pubmed: 15451352
Muscle Nerve. 2002 Dec;26(6):798-803
pubmed: 12451604
Clin Radiol. 2004 Oct;59(10):910-5
pubmed: 15451351
Clin Exp Rheumatol. 2007 Nov-Dec;25(6):853-9
pubmed: 18173919
Arthritis Rheum. 2005 Jan;52(1):304-11
pubmed: 15641050
Rheumatology (Oxford). 2004 Jul;43(7):887-95
pubmed: 15100417
Rev Bras Ortop. 2014 Aug 20;49(5):429-36
pubmed: 26229841
Ergonomics. 1999 Oct;42(10):1350-60
pubmed: 10582504
Ultrasound Med Biol. 2012 Jul;38(7):1121-8
pubmed: 22542258
Clin Neurophysiol. 2008 Sep;119(9):2064-9
pubmed: 18620908
Semin Arthritis Rheum. 2012 Jun;41(6):914-22
pubmed: 22244369
J Ultrasound Med. 2011 Dec;30(12):1657-67
pubmed: 22124001
J Occup Environ Med. 2015 Jan;57(1):98-104
pubmed: 25563546
J Bone Joint Surg Am. 1966 Mar;48(2):211-28
pubmed: 5934271
Ann Plast Surg. 2005 Jan;54(1):20-3
pubmed: 15613877
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):63-7
pubmed: 17470471
J Bone Joint Surg Am. 1993 Nov;75(11):1585-92
pubmed: 8245050
Arthritis Rheum. 2008 Mar 15;59(3):357-66
pubmed: 18311762
AJR Am J Roentgenol. 1999 Sep;173(3):681-4
pubmed: 10470903
J Hand Surg Am. 2002 Nov;27(6):1032-40
pubmed: 12457354
Muscle Nerve. 2014 Aug;50(2):159-63
pubmed: 24633597
Eur J Phys Rehabil Med. 2012 Dec;48(4):665-74; quiz 708
pubmed: 23183452
Ulster Med J. 2008 Jan;77(1):6-17
pubmed: 18269111
Radiology. 2004 Jul;232(1):93-9
pubmed: 15155897
Muscle Nerve. 2012 Aug;46(2):287-93
pubmed: 22806381
Open Orthop J. 2012;6:69-76
pubmed: 22470412
ScientificWorldJournal. 2014 Feb 04;2014:657906
pubmed: 24672350
AJR Am J Roentgenol. 2012 Feb;198(2):W181-4
pubmed: 22268209
Chang Gung Med J. 2008 Sep-Oct;31(5):469-76
pubmed: 19097594

Auteurs

María de la Paz Murciano Casas (MP)

Hospital Virgen Macarena, Sevilla, Spain.

Manuel Rodríguez-Piñero (M)

Hospital Virgen Macarena, Sevilla, Spain.

Aguas-Santas Jiménez Sarmiento (AS)

Hospital Virgen de Valme, Sevilla, Spain.

Mercedes Álvarez López (M)

Hospital Virgen Macarena, Sevilla, Spain.

Gema Jiménez Jurado (G)

Hospital Virgen Macarena, Sevilla, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH